[1] |
王啟瑶,莫霖,李霞,等. 颈内静脉与锁骨下静脉植入静脉输液港的有效性和安全性的Meta分析[J]. 解放军护理杂志,2018,35(22):34-39,47.
|
[2] |
Wu S,Huang J,Jiang Z,et al. Internal jugular vein versus subclavian vein as the percutaneous insertion site for totally implantable venous access devices:a meta-analysis of comparative studies[J]. BMC Cancer,2016,16(1):747.
|
[3] |
Xu H,Chen R,Jiang C,et al. Implanting totally implantable venous access ports in the upper arm is feasible and safe for patients with early breast cancer[J]. J Vasc Access,2020,21(5):609-614.
|
[4] |
Kato K,Iwasaki Y,Onodera K,et al. Totally implantable venous access port via the femoral vein in a femoral port position with CT-venography[J]. J Surg Oncol,2016,114(8):1024-1028
|
[5] |
李全磊,颜美琼,张晓菊,等. PICC经不同静脉和上肢置入对穿刺成功与并发症发生影响的系统评价[J]. 护理学杂志,2012,27(21):56-62.
|
[6] |
Merrer J,De Jonghe B,Golliot F,et al. Complications of femoral and subclavian venous catheterization in critically ill patients:a randomized controlled trial[J]. JAMA,2001,286(6):700-707.
|
[7] |
Parienti JJ,Thirion M,Mégarbane B,et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy:a randomized controlled trial[J]. JAMA,2008,299(20):2413-2422.
|
[8] |
Macdonald S,Watt AJ,McNally D,et al. Comparison of technical success and outcome of tunneled catheters inserted via the jugular and subclavian approaches[J]. J Vasc Interv Radiol,2000,11(2 Pt 1):225-231.
|
[9] |
Collier PE,Ryan JJ,Diamond DL. Cardiac tamponade from central venous catheters. Report of a case and review of the English literature[J]. Angiology,1984,35(9):595-600.
|
[10] |
Chabanier A,Dany F,Brutus P,et al. Iatrogenic cardiac tamponade after central venous catheter[J]. Clin Cardiol,1988,11(2):91-99.
|
[11] |
Sousa B,Furlanetto J,Hutka M,et al. Central venous access in oncology:ESMO Clinical Practice Guidelines[J]. Ann Oncol,2015,Suppl 5:v152-v168.
|
[12] |
Pittiruti M,Hamilton H,Biffi R,et al. ESPEN Guidelines on Parenteral Nutrition:central venous catheters(access,care,diagnosis and therapy of complications)[J]. Clin Nutr,2009,28(4):365-377.
|
[13] |
Glauser F,Breault S,Rigamonti F,et al. Tip malposition of peripherally inserted central catheters:a prospective randomized controlled trial to compare bedside insertion to fluoroscopically guided placement[J]. Eur Radiol,2017,27(7):2843-2849.
|
[14] |
Gebhard RE,Szmuk P,Pivalizza EG,et al. The accuracy of electrocardiogram-controlled central line placement[J]. Anesth Analg,2007,104(1):65-70.
|
[15] |
Practice Guidelines for Central Venous Access 2020:An Updated Report by the American Society of Anesthesiologists Task Force on Central Venous Access[J]. Anesthesiology,2020,132(1):8-43.
|
[16] |
Lamperti M,Bodenham AR,Pittiruti M,et al. International evidence-based recommendations on ultrasound-guided vascular access[J]. Intensive Care Med,2012,38(7):1105-1117.
|
[17] |
Jo JE,Tang EY,Pua BB. The role of antibiotics in preventing totally implantable venous access device(TIVAD)infections;is there a population that would benefit?[J]. Clin Imaging,2018,51:213-216.
|
[18] |
WST/T 433-2013. 静脉治疗护理技术操作规范(WS/T 433-2013[S/OL]. 中国:中华人民共和国国家卫生健康委员会,2013-11-14.
|
[19] |
Gorski LA,Hadaway L,Hagle ME,et al. The 2016 infusion therapy standards of practice[J]. Journal of Infusion Nursing,2016,39(1 Suppl):S1-S159.
|
[20] |
Gorski LA,Hadaway L,Hagle ME,et al. Infusion therapy standards of practice,8th edition[J]. J Infus Nurs,2021,44(1S Suppl 1):S1-S224.
|
[21] |
中华医学会外科学分会乳腺外科学组. 乳腺癌植入式静脉输液港临床应用专家共识及技术操作指南(2017版)[J]. 中国实用外科杂志,2017,37(12):1377-1382.
|
[22] |
孙梅. 不同封管方法对植入式静脉输液港在乳腺癌中应用效果对比研究[J]. 检验医学与临床,2013,10(22):3040-3042.
|
[23] |
李倩芹. 肿瘤病人化疗期间PICC常见并发症的危险因素分析[J]. 全科护理,2021,19(11):1558-1561.
|
[24] |
Schreiber S,Zanchi C,Ronfani L,et al. Normal saline flushes performed once daily maintain peripheral intravenous catheter patency:a randomised controlled trial[J]. Arch Dis Child,2015,100(7):700-703.
|
[25] |
中华人民共和国国家卫生健康委员会. 血管导管相关感染预防与控制指南(2021版)[J]. 中国感染控制杂志,2021,20(04):387-388.
|
[26] |
向泓雨,刘荫华. 制定高质量临床实践指南推动中国乳腺外科诊治规范化进程[J/CD]. 中华普外科手术学杂志(电子版),2022,16(02):119-122.
|